F

4D Molecular Therapeutics
D

FDMT

7.50000
USD
-0.11
(-1.38%)
Market Closed
Volume
28,738
EPS
-3
Div Yield
-
P/E
-3
Market Cap
346,707,818
OverviewSignalsIdeasNews
News

Title: 4D Molecular Therapeutics

Sector: Healthcare
Industry: Biotechnology
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.